InxMed

Beyond's analysis on InxMed

• 2026-07-09 — HanchorBio expands oncology pipeline by partnering with InxMed to explore combination therapies for HCB101

Recent news mentioning InxMed

• 2026-08-28 — InxMed Announces Publication in The Lancet Oncology Featuring Encouraging Antitumor Activity of Ifebemtinib in Combination with Garsorasib in Previously Treated Metastatic Colorectal Cancer (CRC) Harboring KRAS G12C Mutation

Appears alongside

• CRC
• KRAS
• G12C

Browse the full archive →